Skip to content
StockMarketAgent
Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0JDI stock hub

LON/0JDI has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

LON/0JDIis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
9.2B
London Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
LON/0JDI
In the news

Latest news · LON/0JDI

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 12.9P50 16.9P75 23.5
Trailing P/En/a
P25 15.9P50 22.9P75 35.8
ROE-67.6
P25 -54.2P50 2.1P75 13.7
ROIC-45.5
P25 -38.1P50 3.3P75 11.9
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All LON/0JDI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
176
Groups with data
11
Currency
USD
Showing 176 of 176 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

20
MetricValue
Country
United States
Country code
UK
Employees
1,402
Employees Change
333%
Employees Change Percent
31.15
Enterprise value
$9.6B
Exchange
London Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical - Pharmaceuticals
Isin
US4622221004
Last refreshed
2026-05-10
Market cap
$9.2B
Price
$76.48
Price currency
USD
Rev Per Employee
571,592.42x
Sector
Healthcare
Sic
2836
Symbol
lon/0JDI
Website
https://www.ionis.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

7
MetricValue
Earnings Yield
-2.7%
EV Earnings
-38.96x
EV/FCF
-13.11x
EV/Sales
12.42x
FCF yield
-8.01%
P/B ratio
24.67x
P/S ratio
11.46x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

17
MetricValue
EBIT Margin
-33.29%
EBITDA Margin
-32%
Gross margin
10.94%
Gross Profit
$87.6M
Gross Profit Growth5 Y
-5.1%
Net Income
$-247.6M
Net Income Growth Quarters
1%
Net Income Growth Years
1%
Pretax Margin
-30.72%
Profit Margin
-30.9%
Profit Per Employee
$-176,620
ROA
-7.03
Roa5y
-7.19
ROCE
-12.89
ROE
-67.62
Roe5y
-56.83
ROIC
-45.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

11
MetricValue
Cagr1y
135.32%
Cagr3y
29.78%
Cagr5y
15.87%
EPS Growth Quarters
1
EPS Growth Years
1
Revenue Growth
47.53x
Revenue Growth Q
86.98x
Revenue Growth Quarters
1x
Revenue Growth Years
1x
Revenue Growth3 Y
22.48x
Revenue Growth5 Y
8.38x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
$0.34
Assets
$2.6B
Cash
$1.5B
Current Assets
$2.2B
Current Liabilities
$525.6M
Debt
$2B
Debt Equity
$5.31
Debt FCF
$-2.69
Equity
$372.2M
Interest Coverage
-3.91
Liabilities
$2.2B
Long Term Assets
$458.4M
Long Term Liabilities
$1.7B
Net Cash
$-479.1M
Net Cash By Market Cap
$-5.22
Net Debt Equity
$1.29
Tangible Book Value
$372.2M
Tangible Book Value Per Share
$2.24
WACC
5.71

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
4.1
Inventory Turnover
110.5
Net Working Capital
$520.1M
Quick ratio
2.86
Working Capital
$1.7B
Working Capital Turnover
$0.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-5.71%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
135.18%
200-day SMA
70.12
3Y total return
118.64%
50-day SMA
74.74
50-day SMA vs 200-day SMA
50over200
5Y total return
108.79%
All Time High
86.72
All Time High Change
-11.81%
All Time High Date
2026-02-05
All Time Low
24.11
All Time Low Change
217.21%
All Time Low Date
2025-04-09
ATR
2.49
Beta
0.38
Ch YTD
-3.76
High
77.75
High52
86.72
High52 Date
2026-02-05
High52ch
-11.81%
Low
75.77
Low52
32.44
Low52 Date
2025-05-14
Low52ch
135.76%
Ma50ch
2.33%
Price vs 200-day SMA
9.07%
RSI
57.87
RSI Monthly
68.4
RSI Weekly
56.56
Sharpe ratio
1.99x
Sortino ratio
5.04
Total Return
-5.71%
Tr YTD
-3.76
Tr1m
3.39%
Tr1w
1.16%
Tr3m
-11.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
$-266.8M
Operating margin
-33.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
163,979,405%
Net Borrowing
368,358,261.1
Shares Insiders
0.74%
Shares Institutions
104.94%
Shares Qo Q
1.77%
Shares Yo Y
5.71%
Short Ratio
6.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

51
MetricValue
Adjusted FCF
$-847.2M
Average Volume
12,078.75x
Bv Per Share
2.24
CAPEX
$-45.9M
Ch1m
3.39
Ch1w
1.16
Ch1y
135.2
Ch3m
-11.06
Ch3y
118.6
Ch5y
108.8
Ch6m
4.82
Change
1.74%
Change From Open
-1.63
Close
75.17
Days Gap
3.43
Depreciation Amortization
9,975,056.9
Dollar Volume
3,977
Earnings Date
2026-07-29
EBIT
$-266.8M
EBITDA
$-256.5M
EPS
$-1.53
F Score
2
FCF
$-735.5M
FCF EV Yield
-7.62x
Financing CF
553,513,467
Fiscal Year End
December
Founded
1,989
Income Tax
$1.4M
Investing CF
67,085,863
Is Primary Listing
0
Last Earnings Date
2026-02-18
Last Report Date
2026-03-31
Ma150
76.63
Ma150ch
-0.19%
Ma20
74.88
Ma20ch
2.14%
Net CF
-68,771,624
Next Earnings Date
2026-07-29
Open
77.75
Position In Range
35.86
Ppne
276,875,862
Price Date
2026-05-08
Ptbv Ratio
24.67
Relative Volume
0x
Revenue
801,372,578x
SBC By Revenue
13.93x
Share Based Comp
111,650,233
Tax By Revenue
0.18x
Tr6m
4.82%
Volume
52
Z Score
1.56
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does LON/0JDI pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0JDI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
+135.2%
S&P 500 1Y: n/a
3Y total return
+118.6%
S&P 500 3Y: n/a
5Y total return
+108.8%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns LON/0JDI?

Insider, institutional, and short-interest positioning.

Institutional ownership
+104.9%
Share of float held by funds and institutions
Insider ownership
+0.7%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
6.6 days to cover
Y/Y dilution
+5.7%
Negative means the company is buying back shares.
Technical

LON/0JDI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
57.9
Neutral momentum band
Price vs 200-day MA
+9.1%
50/200-day relationship not available
Beta (5Y)
0.38
Less volatile than the market
Sharpe ratio
1.99
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About LON/0JDI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0JDI stock rating?

lon/0JDI is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0JDI analysis?

The full report lives at /stocks/lon/0JDI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0JDI?

The latest report frames lon/0JDI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0JDI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.